PT  - JOURNAL ARTICLE
ED  - ,
TI  - Correction: Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design
AID  - 10.1136/jitc-2021-003149corr1
DP  - 2021 Oct 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e003149corr1
VI  - 9
IP  - 10
4099  - http://jitc.bmj.com/content/9/10/e003149corr1.short
4100  - http://jitc.bmj.com/content/9/10/e003149corr1.full
SO  - J Immunother Cancer2021 Oct 01; 9